A Phase 2, Randomized, Double-Bling, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects with NASH Read more about A Phase 2, Randomized, Double-Bling, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects with NASH
A Phase 2, Randomized, Double-Bling, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects with NASH Read more about A Phase 2, Randomized, Double-Bling, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects with NASH
A Phase 2, Randomized, Double-Bling, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects with NASH Read more about A Phase 2, Randomized, Double-Bling, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects with NASH
A Phase 2, Randomized, Double-Bling, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects with NASH Read more about A Phase 2, Randomized, Double-Bling, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects with NASH
A Phase 2, Randomized, Double-Bling, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects with NASH Read more about A Phase 2, Randomized, Double-Bling, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects with NASH
A Phase 2, Randomized, Double-Bling, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects with NASH Read more about A Phase 2, Randomized, Double-Bling, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects with NASH
A Phase 2, Randomized, Double-Bling, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects with NASH Read more about A Phase 2, Randomized, Double-Bling, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects with NASH
Partnership for Trauma Smart New York City Evaluation Read more about Partnership for Trauma Smart New York City Evaluation
Partnership for Trauma Smart Expansion Evaluation Read more about Partnership for Trauma Smart Expansion Evaluation
Pre-Clinical Assessment of Epstein-Barr Virus Cancer Vaccines Read more about Pre-Clinical Assessment of Epstein-Barr Virus Cancer Vaccines
